NBT Bank’s Apellis Pharmaceuticals APLS Stock Holding History

NBT Bank’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-45	Closed	-$1.81K	–	1069
2026 Q1	$1.81K	Buy	+45	New	+$970	﹤0.01%	820

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

NBT Bank's APLS Position: Q2 2026 in Review

NBT Bank sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 45 shares — an estimated $1.81K sold.

NBT Bank first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $1.81K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

NBT Bank reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
NBT Bank sold 45 Apellis Pharmaceuticals shares in Q2 2026, an estimated $1.81K.
NBT Bank first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
NBT Bank's Apellis Pharmaceuticals position peaked at $1.81K in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on NBT Bank's 13F filing for Q2 2026, filed 29 Jul 2026.